Product Code: TMRGL67523
TMR's report on the global acute kidney injury treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global acute kidney injury treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global acute kidney injury treatment market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the acute kidney injury treatment market.
The report delves into the competitive landscape of the global acute kidney injury treatment market. Key players operating in the global acute kidney injury treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global acute kidney injury treatment market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
- 2.1. Assumptions and Acronyms Used
- 2.2. Research Methodology
3. Executive Summary
- 3.1. Global Acute Kidney Injury Treatment Market: Market Snapshot
4. Market Overview
- 4.1. Global Acute Kidney Injury Treatment Market: Overview
- 4.2. Global Acute Kidney Injury Treatment Market: Key Industry Developments
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Acute Kidney Injury Treatment Market Revenue Projection, 2017-2031
- 4.5. Global Acute Kidney Injury Treatment Market Outlook
5. Market Outlook
- 5.1. Acute Kidney Injury Epidemiology: Overview
- 5.2. Key Merger and Acquisitions
- 5.3. Pipeline Analysis
- 5.4. CCOVID-19 Impact on Industry
6. Global Acute Kidney Injury Treatment Market Analysis, by Treatment
- 6.1. Key Findings
- 6.2. Introduction
- 6.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Treatment
- 6.4. Global Acute Kidney Injury Treatment Market Value Forecast, by Treatment
- 6.4.1. Dialysis
- 6.4.2. Supportive Care
- 6.5. Global Acute Kidney Injury Treatment Market Analysis, by Treatment
7. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, by Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Type
- 7.4. Global Acute Kidney Injury Treatment Market Value Forecast, by Type
- 7.4.1. Pre-renal Acute Kidney Injury
- 7.4.2. Intrinsic Renal Acute Kidney Injury
- 7.4.3. Post-renal Acute Kidney Injury
- 7.5. Global Acute Kidney Injury Treatment Market Analysis, by Type
8. Global Acute Kidney Injury Treatment Market Analysis, by End-user
- 8.1. Key Findings
- 8.2. Introduction
- 8.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by End-user
- 8.4. Global Acute Kidney Injury Treatment Market Value Forecast, by End-user
- 8.4.1. Hospitals
- 8.4.2. Ambulatory Surgical Centers
- 8.4.3. Others
- 8.5. Global Acute Kidney Injury Treatment Market Analysis, by End-user
9. Global Acute Kidney Injury Treatment Market Analysis, by Region
- 9.1. Global Acute Kidney Injury Treatment Market Scenario, by Country
- 9.2. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Region
- 9.3. Global Acute Kidney Injury Treatment Market Value Forecast, by Region
- 9.3.1. North America
- 9.3.2. Europe
- 9.3.3. Asia Pacific
- 9.3.4. Latin America
- 9.3.5. Middle East & Africa
10. North America Acute Kidney Injury Treatment Market Analysis
- 10.1. Key Findings
- 10.2. North America Acute Kidney Injury Treatment Market Overview
- 10.3. North America Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country
- 10.4. North America Acute Kidney Injury Treatment Market Forecast, by Country
- 10.4.1. U.S.
- 10.4.2. Canada
- 10.5. North America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
- 10.6. North America Acute Kidney Injury Treatment Market Forecast, by Treatment
- 10.6.1. Dialysis
- 10.6.2. Supportive Care
- 10.7. North America Acute Kidney Injury Treatment Market Value Share Analysis, by Type
- 10.8. North America Acute Kidney Injury Treatment Market Forecast, by Type
- 10.8.1. Pre-renal Acute Kidney Injury
- 10.8.2. Intrinsic Renal Acute Kidney Injury
- 10.8.3. Post-renal Acute Kidney Injury
- 10.9. North America Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
- 10.10. North America Acute Kidney Injury Treatment Market Forecast, by End-user
- 10.10.1. Hospitals
- 10.10.2. Ambulatory surgical centers
- 10.10.3. Others
- 10.11. North America Acute Kidney Injury Treatment Market Attractiveness Analysis
11. Europe Acute Kidney Injury Treatment Market Analysis
- 11.1. Key Findings
- 11.2. Europe Acute Kidney Injury Treatment Market Overview
- 11.3. Europe Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
- 11.4. Europe Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
- 11.4.1. Germany
- 11.4.2. U.K.
- 11.4.3. France
- 11.4.4. Italy
- 11.4.5. Spain
- 11.4.6. Rest of Europe
- 11.5. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
- 11.6. Europe Acute Kidney Injury Treatment Market Forecast, by Treatment
- 11.6.1. Dialysis
- 11.6.2. Supportive Care
- 11.7. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Type
- 11.8. Europe Acute Kidney Injury Treatment Market Forecast, by Type
- 11.8.1. Pre-renal Acute Kidney Injury
- 11.8.2. Intrinsic Renal Acute Kidney Injury
- 11.8.3. Post-renal Acute Kidney Injury
- 11.9. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
- 11.10. Europe Acute Kidney Injury Treatment Market Forecast, by End-user
- 11.10.1. Hospitals
- 11.10.2. Ambulatory Surgical Centers
- 11.10.3. Others
- 11.11. Europe Acute Kidney Injury Treatment Market Attractiveness Analysis
12. Asia Pacific Acute Kidney Injury Treatment Market Analysis
- 12.1. Key Findings
- 12.2. Asia Pacific Acute Kidney Injury Treatment Market Overview
- 12.3. Asia Pacific Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
- 12.4. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
- 12.4.1. China
- 12.4.2. India
- 12.4.3. Japan
- 12.4.4. Australia & New Zealand
- 12.4.5. Rest of Asia Pacific
- 12.5. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
- 12.6. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Treatment
- 12.6.1. Dialysis
- 12.6.2. Supportive Care
- 12.7. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Type
- 12.8. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Type
- 12.8.1. Pre-renal Acute Kidney Injury
- 12.8.2. Intrinsic Renal Acute Kidney Injury
- 12.8.3. Post-renal Acute Kidney Injury
- 12.9. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
- 12.10. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by End-user
- 12.10.1. Hospitals
- 12.10.2. Ambulatory Surgical Centers
- 12.10.3. Others
- 12.11. Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis
13. Latin America Acute Kidney Injury Treatment Market Analysis
- 13.1. Key Findings
- 13.2. Latin America Acute Kidney Injury Treatment Market Overview
- 13.3. Latin America Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
- 13.4. Latin America Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
- 13.4.1. Brazil
- 13.4.2. Mexico
- 13.4.3. Rest of Latin America
- 13.5. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
- 13.6. Latin America Acute Kidney Injury Treatment Market Forecast, by Treatment
- 13.6.1. Dialysis
- 13.6.2. Supportive Care
- 13.7. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Type
- 13.8. Latin America Acute Kidney Injury Treatment Market Forecast, by Type
- 13.8.1. Pre-renal Acute Kidney Injury
- 13.8.2. Intrinsic Renal Acute Kidney Injury
- 13.8.3. Post-renal Acute Kidney Injury
- 13.9. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
- 13.10. Latin America Acute Kidney Injury Treatment Market Forecast, by End-user
- 13.10.1. Hospitals
- 13.10.2. Ambulatory Surgical Centers
- 13.10.3. Others
- 13.11. Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis
14. Middle East & Africa Acute Kidney Injury Treatment Market Analysis
- 14.1. Key Findings
- 14.2. Middle East & Africa Acute Kidney Injury Treatment Market Overview
- 14.3. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region
- 14.4. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
- 14.4.1. GCC Countries
- 14.4.2. South Africa
- 14.4.3. Rest of Middle East and Africa
- 14.5. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
- 14.6. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Treatment
- 14.6.1. Dialysis
- 14.6.2. Supportive Care
- 14.7. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Type
- 14.8. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Type
- 14.8.1. Pre-renal Acute Kidney Injury
- 14.8.2. Intrinsic Renal Acute Kidney Injury
- 14.8.3. Post-renal Acute Kidney Injury
- 14.9. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
- 14.10. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by End-user
- 14.10.1. Hospitals
- 14.10.2. Ambulatory Surgical Centers
- 14.10.3. Others
- 14.11. Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis
15. Competition Landscape
- 15.1. Acute Kidney Injury Treatment Market Share Analysis, by Company, 2021
- 15.2. Competition Matrix
- 15.3. Company Profiles
- 15.3.1. Angion Biomedica Corp
- 15.3.1.1. Company Details
- 15.3.1.2. Business Overview
- 15.3.1.3. Financial Overview
- 15.3.1.4. Strategic Overview
- 15.3.1.5. SWOT Analysis
- 15.3.2. AM-Pharma
- 15.3.2.1. Company Details
- 15.3.2.2. Business Overview
- 15.3.2.3. Financial Overview
- 15.3.2.4. Strategic Overview
- 15.3.2.5. SWOT Analysis
- 15.3.3. Quark Pharmaceuticals, Inc.
- 15.3.3.1. Company Details
- 15.3.3.2. Business Overview
- 15.3.3.3. Financial Overview
- 15.3.3.4. Strategic Overview
- 15.3.3.5. SWOT Analysis
- 15.3.4. Baxter International, Inc.
- 15.3.4.1. Company Details
- 15.3.4.2. Business Overview
- 15.3.4.3. Financial Overview
- 15.3.4.4. Strategic Overview
- 15.3.4.5. SWOT Analysis
- 15.3.5. Fresenius Medical Care AG & Co. KGaA
- 15.3.5.1. Company Details
- 15.3.5.2. Business Overview
- 15.3.5.3. Financial Overview
- 15.3.5.4. Strategic Overview
- 15.3.5.5. SWOT Analysis
- 15.3.6. LG Chem
- 15.3.6.1. Company Details
- 15.3.6.2. Business Overview
- 15.3.6.3. Financial Overview
- 15.3.6.4. Strategic Overview
- 15.3.6.5. SWOT Analysis
- 15.3.7. Asahi Kasei Medical Co., Ltd.
- 15.3.7.1. Company Details
- 15.3.7.2. Business Overview
- 15.3.7.3. Financial Overview
- 15.3.7.4. Strategic Overview
- 15.3.7.5. SWOT Analysis
- 15.3.8. B. Braun Melsungen AG
- 15.3.8.1. Company Details
- 15.3.8.2. Business Overview
- 15.3.8.3. Financial Overview
- 15.3.8.4. Strategic Overview
- 15.3.8.5. SWOT Analysis